fitting software origin pro 9.0 Search Results


94
Miltenyi Biotec fitc rat monoclonal anti mouse cd38
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fitc Rat Monoclonal Anti Mouse Cd38, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc rat monoclonal anti mouse cd38/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
fitc rat monoclonal anti mouse cd38 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Garmin Ltd garmin vívosmart 4
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Garmin Vívosmart 4, supplied by Garmin Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/garmin vívosmart 4/product/Garmin Ltd
Average 90 stars, based on 1 article reviews
garmin vívosmart 4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Chenomx Inc spectral analysis software
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Spectral Analysis Software, supplied by Chenomx Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/spectral analysis software/product/Chenomx Inc
Average 90 stars, based on 1 article reviews
spectral analysis software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
STATA Corporation xtreg command
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Xtreg Command, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xtreg command/product/STATA Corporation
Average 96 stars, based on 1 article reviews
xtreg command - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
STATA Corporation version 9.2 se
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Version 9.2 Se, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/version 9.2 se/product/STATA Corporation
Average 90 stars, based on 1 article reviews
version 9.2 se - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc bell-shaped curve nonlinear regression
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Bell Shaped Curve Nonlinear Regression, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bell-shaped curve nonlinear regression/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
bell-shaped curve nonlinear regression - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
DataPhysics Instruments dpimax version 1.51.90.75 software
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Dpimax Version 1.51.90.75 Software, supplied by DataPhysics Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dpimax version 1.51.90.75 software/product/DataPhysics Instruments
Average 90 stars, based on 1 article reviews
dpimax version 1.51.90.75 software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc prism fitting software
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Prism Fitting Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prism fitting software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
prism fitting software - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STATA Corporation fractional polynomial procedure
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fractional Polynomial Procedure, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fractional polynomial procedure/product/STATA Corporation
Average 90 stars, based on 1 article reviews
fractional polynomial procedure - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
STATA Corporation square residual 0 07 comparative fit index 0 90 akaike information criteria and the model c2 test 49 data were analyzed using stata version 15 1
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Square Residual 0 07 Comparative Fit Index 0 90 Akaike Information Criteria And The Model C2 Test 49 Data Were Analyzed Using Stata Version 15 1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/square residual 0 07 comparative fit index 0 90 akaike information criteria and the model c2 test 49 data were analyzed using stata version 15 1/product/STATA Corporation
Average 99 stars, based on 1 article reviews
square residual 0 07 comparative fit index 0 90 akaike information criteria and the model c2 test 49 data were analyzed using stata version 15 1 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

99
Nikon ez c1 3 90 freeviewer software
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Ez C1 3 90 Freeviewer Software, supplied by Nikon, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ez c1 3 90 freeviewer software/product/Nikon
Average 99 stars, based on 1 article reviews
ez c1 3 90 freeviewer software - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
STATA Corporation poisson regression models stata version 9.2
(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − <t>CD38</t> hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Poisson Regression Models Stata Version 9.2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poisson regression models stata version 9.2/product/STATA Corporation
Average 90 stars, based on 1 article reviews
poisson regression models stata version 9.2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − CD38 hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Journal: Cell reports

Article Title: Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity

doi: 10.1016/j.celrep.2021.109525

Figure Lengend Snippet: (A–C) Flow cytometry dot plots showing gating of peripheral blood B cell subsets. (D and E) CD45 phosphatase activity (D) and panCD45 surface expression (E) in human MBC and ASC subpopulations (red) compared to naive B cells (blue). Numbers in the histograms represent MFI ratio relative to naive B cells. (F and G) Graphs show pCAP-SP1 (F) and panCD45 surface expression (G) MFI values relative to naive B cells (n= 12). (H) Human BM CD19 − CD38 hi CD138 + (left panel) and CD19 + CD138 +/− CD38 + (right panel) previously shown to contain LLPCs and SLPCs, respectively. (I) CD45 phosphatase activity (left panel), CD45 surface expression (middle panel), and BLIMP1 expression (right panel) in LLPCs (red) and SLPCs (blue) relative to mature BM B cells (CD19 + SSC lo CD45 hi ) obtained from the same donor (gray). (J) Graphs show fold change in MFI of CD45 phosphatase activity (left panel) and CD45 surface expression (right panel) from human BM PCs relative to mature BM B cells from the same healthy donor (n = 4). Related to . *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Article Snippet: FITC Rat monoclonal anti-mouse CD38 (clone 90.4) , Miltenyi Biotec , Cat # 130–102-514; RRID:AB_2657875.

Techniques: Flow Cytometry, Activity Assay, Expressing

(A) Flow cytometry plots show gated CD38 hi CD138 hi ASCs (upper panel) and CD45 activity versus CD138 expression (lower panel) in the presence of Th signals and CD45 inhibitor as indicated. (B) Graph shows % CD38 hi CD138 hi ASC B cells (n= 8). (C) Histograms show the CD45-dependent regulation of ASC-associated markers and transcription factors. CTR+VEH (gray), CD40L+VEH (blue), CD40L+CD45 inhibitor (red). (D) Human peripheral B cells differentiated toward ASCs in the presence of CTR siRNA (upper panels) or CD45 siRNA (lower panels). (E) Graph shows % IRF4 + BLIMP1 + ASCs upon delivery of CTR or CD45 siRNA (n = 5). (F) Flow cytometry histograms show expression of CD45 activity (upper left panel), CD45 surface expression (upper right panel), BLIMP1 (lower left panel), and IRF4 (lower right panel) in purified B cells differentiated toward ASCs in the presence of CTR siRNA (gray) or CD45 siRNA (blue). Related to . *p < 0.05, **p < 0.01, ***p < 0.001.

Journal: Cell reports

Article Title: Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity

doi: 10.1016/j.celrep.2021.109525

Figure Lengend Snippet: (A) Flow cytometry plots show gated CD38 hi CD138 hi ASCs (upper panel) and CD45 activity versus CD138 expression (lower panel) in the presence of Th signals and CD45 inhibitor as indicated. (B) Graph shows % CD38 hi CD138 hi ASC B cells (n= 8). (C) Histograms show the CD45-dependent regulation of ASC-associated markers and transcription factors. CTR+VEH (gray), CD40L+VEH (blue), CD40L+CD45 inhibitor (red). (D) Human peripheral B cells differentiated toward ASCs in the presence of CTR siRNA (upper panels) or CD45 siRNA (lower panels). (E) Graph shows % IRF4 + BLIMP1 + ASCs upon delivery of CTR or CD45 siRNA (n = 5). (F) Flow cytometry histograms show expression of CD45 activity (upper left panel), CD45 surface expression (upper right panel), BLIMP1 (lower left panel), and IRF4 (lower right panel) in purified B cells differentiated toward ASCs in the presence of CTR siRNA (gray) or CD45 siRNA (blue). Related to . *p < 0.05, **p < 0.01, ***p < 0.001.

Article Snippet: FITC Rat monoclonal anti-mouse CD38 (clone 90.4) , Miltenyi Biotec , Cat # 130–102-514; RRID:AB_2657875.

Techniques: Flow Cytometry, Activity Assay, Expressing, Purification

(A) Representative dot plots showing LN GC B cells (B220 + GL7 + CD38 − ) and high- and low-affinity HA-reactive cells; HA binding versus IgG expression is shown. (B) Histograms show CD45 activity (left) and IRF4 expression (right) in GC low- (blue-filled histograms) and high-affinity (red) B cells. (C) BM PCs gated as Blimp1 + CD138 + cells (green) overlayed on histograms of low- (blue) and high-affinity (red) GC B cells showing CD45 activity (left) and Blimp1 (middle) and CD138 (right) expression levels. (D) Dot plots show BM PC gate from forward and side scatter (F/SSC)-gated cells (left) and from B220 + SSC lo -gated cells (right). (E) PCs were backgated on dot plots depicting CD45 activity and Blimp1 (left) and CD45 activity and IRF4 (right); PCs are depicted as red dots, BM B220 + B cells are represented in blue. (F) PCs (red) and B220 + B cells (blue) were analyzed for CD45 activity (left) and HA binding (right). (G and H) Graphs show MFI of CD45 activity of low-affinity (LoAff) and high-affinity (HiAff) GC B cells and BM PCs relative to B220 + B cells within the same sample (LN or BM). (I) Graph shows MFI ratio of HA normalized to IgG. Data are representative of two experiments including seven immunized mice in addition to immunization and staining controls. Related to . *p < 0.05, **p < 0.01.

Journal: Cell reports

Article Title: Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity

doi: 10.1016/j.celrep.2021.109525

Figure Lengend Snippet: (A) Representative dot plots showing LN GC B cells (B220 + GL7 + CD38 − ) and high- and low-affinity HA-reactive cells; HA binding versus IgG expression is shown. (B) Histograms show CD45 activity (left) and IRF4 expression (right) in GC low- (blue-filled histograms) and high-affinity (red) B cells. (C) BM PCs gated as Blimp1 + CD138 + cells (green) overlayed on histograms of low- (blue) and high-affinity (red) GC B cells showing CD45 activity (left) and Blimp1 (middle) and CD138 (right) expression levels. (D) Dot plots show BM PC gate from forward and side scatter (F/SSC)-gated cells (left) and from B220 + SSC lo -gated cells (right). (E) PCs were backgated on dot plots depicting CD45 activity and Blimp1 (left) and CD45 activity and IRF4 (right); PCs are depicted as red dots, BM B220 + B cells are represented in blue. (F) PCs (red) and B220 + B cells (blue) were analyzed for CD45 activity (left) and HA binding (right). (G and H) Graphs show MFI of CD45 activity of low-affinity (LoAff) and high-affinity (HiAff) GC B cells and BM PCs relative to B220 + B cells within the same sample (LN or BM). (I) Graph shows MFI ratio of HA normalized to IgG. Data are representative of two experiments including seven immunized mice in addition to immunization and staining controls. Related to . *p < 0.05, **p < 0.01.

Article Snippet: FITC Rat monoclonal anti-mouse CD38 (clone 90.4) , Miltenyi Biotec , Cat # 130–102-514; RRID:AB_2657875.

Techniques: Binding Assay, Expressing, Activity Assay, Staining

(A) Flow cytometry histogram showing surface staining of Galectin-1 in naive (gray), memory (blue), and PCs (red) in human peripheral blood B cells (left panel). Isotype control is shown by gray-dotted histogram. Graph shows fold increase in surface Galectin-1 staining (MFI) relative to naive B cells (n = 4). Contour plot depicts CD45 activity versus Galectin-1 surface staining in B cells (blue) and PCs (CD138 hi CD38 hi ) (red) backgated to CD45 activity hi Galectin-1 hi cells (right panel). (B) Histograms show CD45 activity (left panel), Galectin-1 staining (middle panel), and MEM-55 staining (right panel) in CTR- or NA-treated B cells. Graphs show fold increase in MFI of CD45 phosphatase activity (left lower panel) and Galectin-1 staining (right lower panel) relative to CTR-treated B cells (n = 6). (C) Upper panels: Dot plots show expression of IRF4 and BLIMP1 in naive B cells and MBCs differentiated toward ASCs in the presence of 10 and 100 µM OTX008 or VEH. Graph shows % IRF4 + BLIMP1 + B cells in MBC cultures. Lower panels: Galectin-1 surface expression (left panel) and CD45 phosphatase activity (right panel) in VEH-treated (blue histogram) and OTX-treated (blue dotted histogram) MBCs. Graphs show MFI values of Galectin-1 staining (left) and CD45 activity (right) (n = 5). (D) Flow cytometry dot plots show CD45 activity versus Galectin-1 surface staining in the presence of medium or rhGAL-1 (left panels). Histogram shows CD45 phosphatase activity of Galectin-1 hi B cells with rhGAL1 (blue) and total B cells (gray) (middle panel). Graph shows MFI values of CD45 activity in total B cells (gray histogram) and GAL-1 hi (blue open histogram) B cells (right panel) (n = 6). (E) Representative localization of Galectin-1 relative to pSyk, pCAP-SP1, and CD45 in human B cells. The panels (left) present signals from the individual fluorescence detectors, and the center image is a merge of all four channels. The graph (right) shows the average (z axis) fluorescence intensity for each (x axis) pixel number in the indicated area (below graph and dotted area on center figure). (F) CoIP of CD45 of B cell lysates and immunoblotted with anti-CD45 (left) or anti-Galectin-1 (right). (G) Flow cytometry histogram showing CD45 phosphatase activity in gated live Raji B cells with CRISPR-Cas9 knockdown of CD45 (blue), Galectin-1 (green), and wild-type (red). Related to and . *p < 0.05, **p < 0.01.

Journal: Cell reports

Article Title: Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity

doi: 10.1016/j.celrep.2021.109525

Figure Lengend Snippet: (A) Flow cytometry histogram showing surface staining of Galectin-1 in naive (gray), memory (blue), and PCs (red) in human peripheral blood B cells (left panel). Isotype control is shown by gray-dotted histogram. Graph shows fold increase in surface Galectin-1 staining (MFI) relative to naive B cells (n = 4). Contour plot depicts CD45 activity versus Galectin-1 surface staining in B cells (blue) and PCs (CD138 hi CD38 hi ) (red) backgated to CD45 activity hi Galectin-1 hi cells (right panel). (B) Histograms show CD45 activity (left panel), Galectin-1 staining (middle panel), and MEM-55 staining (right panel) in CTR- or NA-treated B cells. Graphs show fold increase in MFI of CD45 phosphatase activity (left lower panel) and Galectin-1 staining (right lower panel) relative to CTR-treated B cells (n = 6). (C) Upper panels: Dot plots show expression of IRF4 and BLIMP1 in naive B cells and MBCs differentiated toward ASCs in the presence of 10 and 100 µM OTX008 or VEH. Graph shows % IRF4 + BLIMP1 + B cells in MBC cultures. Lower panels: Galectin-1 surface expression (left panel) and CD45 phosphatase activity (right panel) in VEH-treated (blue histogram) and OTX-treated (blue dotted histogram) MBCs. Graphs show MFI values of Galectin-1 staining (left) and CD45 activity (right) (n = 5). (D) Flow cytometry dot plots show CD45 activity versus Galectin-1 surface staining in the presence of medium or rhGAL-1 (left panels). Histogram shows CD45 phosphatase activity of Galectin-1 hi B cells with rhGAL1 (blue) and total B cells (gray) (middle panel). Graph shows MFI values of CD45 activity in total B cells (gray histogram) and GAL-1 hi (blue open histogram) B cells (right panel) (n = 6). (E) Representative localization of Galectin-1 relative to pSyk, pCAP-SP1, and CD45 in human B cells. The panels (left) present signals from the individual fluorescence detectors, and the center image is a merge of all four channels. The graph (right) shows the average (z axis) fluorescence intensity for each (x axis) pixel number in the indicated area (below graph and dotted area on center figure). (F) CoIP of CD45 of B cell lysates and immunoblotted with anti-CD45 (left) or anti-Galectin-1 (right). (G) Flow cytometry histogram showing CD45 phosphatase activity in gated live Raji B cells with CRISPR-Cas9 knockdown of CD45 (blue), Galectin-1 (green), and wild-type (red). Related to and . *p < 0.05, **p < 0.01.

Article Snippet: FITC Rat monoclonal anti-mouse CD38 (clone 90.4) , Miltenyi Biotec , Cat # 130–102-514; RRID:AB_2657875.

Techniques: Flow Cytometry, Staining, Control, Activity Assay, Expressing, Fluorescence, CRISPR, Knockdown

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity

doi: 10.1016/j.celrep.2021.109525

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: FITC Rat monoclonal anti-mouse CD38 (clone 90.4) , Miltenyi Biotec , Cat # 130–102-514; RRID:AB_2657875.

Techniques: Negative Control, Recombinant, Purification, Staining, Gene Expression, Lysis, Immunoprecipitation, Plasmid Preparation, Enzyme-linked Immunosorbent Assay, Blocking Assay, Cell Isolation, Software, Microscopy